APA (7th ed.) Citation

CW, W., IJG, B., N, G., A, R., A, M., D, C., . . . AM, S. (2023). Preclinical radiolabeling, in vivo biodistribution and positron emission tomography of a novel pyrrolobenzodiazepine (PBD)-based antibody drug conjugate targeting ASCT2. Nuclear medicine and biology, 122-123, 108366. https://doi.org/10.1016/j.nucmedbio.2023.108366

Chicago Style (17th ed.) Citation

CW, Wichmann, et al. "Preclinical Radiolabeling, in Vivo Biodistribution and Positron Emission Tomography of a Novel Pyrrolobenzodiazepine (PBD)-based Antibody Drug Conjugate Targeting ASCT2." Nuclear Medicine and Biology 122-123 (2023): 108366. https://doi.org/10.1016/j.nucmedbio.2023.108366.

MLA (9th ed.) Citation

CW, Wichmann, et al. "Preclinical Radiolabeling, in Vivo Biodistribution and Positron Emission Tomography of a Novel Pyrrolobenzodiazepine (PBD)-based Antibody Drug Conjugate Targeting ASCT2." Nuclear Medicine and Biology, vol. 122-123, 2023, p. 108366, https://doi.org/10.1016/j.nucmedbio.2023.108366.